XtalPi Holdings Limited (XtalPi, 2228) announced the successful deployment of an automated formulation stability testing workstation at BASF, a major global chemical company. This collaboration enables BASF to build an end-to-end automated system that integrates sample management, analytical testing, and data management.

According to the announcement, the project exemplifies XtalPi’s chemical automation leadership. Its modular design approach and robotic laboratory platforms support rapid deployment, operational stability, and innovative customization. The system is designed to generate high-precision data for research and development (R&D) processes across industries, fueling the development of advanced AI models.

The statement highlights that XtalPi’s solutions are deployed in sectors such as pharmaceuticals, petrochemicals, new energy, and advanced materials. The company’s growing portfolio of projects includes established global pharmaceutical firms, industrial leaders like Sinopec, and institutes such as Fudan University and the Singapore Agency for Science, Technology, and Research (A*STAR). These implementations support the shift toward standardized, large-scale robotic experimentation and continuous data generation, aligning with broader trends in AI-driven R&D.

The announcement also notes BASF’s global reach in chemicals, materials, industrial solutions, and nutrition and care, indicating the significance of the partnership in enhancing automated lab capabilities. As part of XtalPi’s strategic expansion, the deployment underscores the company’s ambitions to bring scalable laboratory automation to high-value industries, supporting the move toward digital and intelligent transformation in modern research.